Your browser doesn't support javascript.
loading
Investigation Into Novel Mukanadin B, Mukanadin D and Mukanadin F Derivatives as Antagonists of 5-HT1A Signalling.
Rees, Shaun W P; Rees, Tayla A; van Rensburg, Michelle; Walker, Christopher S; Pilkington, Lisa I; Barker, David.
Afiliação
  • Rees SWP; School of Chemical Sciences, University of Auckland, Auckland, 1010, New Zealand.
  • Rees TA; School of Biological Science, University of Auckland, Auckland, 1010, New Zealand.
  • van Rensburg M; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, 1010, New Zealand.
  • Walker CS; School of Chemical Sciences, University of Auckland, Auckland, 1010, New Zealand.
  • Pilkington LI; School of Biological Science, University of Auckland, Auckland, 1010, New Zealand.
  • Barker D; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, 1010, New Zealand.
ChemMedChem ; 19(15): e202400102, 2024 Aug 01.
Article em En | MEDLINE | ID: mdl-38661010
ABSTRACT
Marine bromopyrrole alkaloids are a diverse family of natural products with a large array of biological applications. The mukanadin family is a group of molecules consisting of seven members (mukanadin A-G) that possess a range of biological activities. Inhibition of serotonergic signaling has been demonstrated by mukanadin B derivatives, presenting this chemical scaffold as a candidate for further SAR exploration. A library of thirteen novel mukanadin B and D derivatives with structural variation targeted at the pyrrole ring, central linker and hydantoin ring, were synthesized. These analogues were subsequently assessed for serotonergic antagonism, in addition to natural products, mukanadin B, D, F and 9-hydroxy mukanadin B. A collection of compounds exhibited significant 5-HT1A signaling, including five of the novel derivatives and two of the naturally occurring bromopyrroles, mukanadin B and F. Particular SAR information could be determined from these results, such as modification of the pyrrole ring being a well-tolerated strategy for improving serotonergic inhibition. Other changes to the pharmacophore led to significant reduction in activity such as saturation of the linker region, or no conclusive improvement in inhibitory activity such as a 9-OH group or replacement of the hydantoin ring with a triazole moiety.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirróis / Transdução de Sinais / Receptor 5-HT1A de Serotonina Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirróis / Transdução de Sinais / Receptor 5-HT1A de Serotonina Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article